Institutional academic-industry relationships

JAMA

Volumn 298, Issue 15, 2007, Pages 1779-1786

  Campbell, Eric G ^a,d   Weissman, Joel S ^a   Ehringhaus, Susan ^c   Rao, Sowmya R ^a   Moy, Beverly ^a   Feibelmann, Sandra ^a   Goold, Susan Dorr ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ASSOCIATION OF AMERICAN MEDICAL COLLEGES   (United States)

^d Institute for Health Policy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; CONSULTATION; FUNDING; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH SURVEY; LICENSING; MEDICAL EDUCATION; MEDICAL INSTRUMENTATION; MEDICAL RESEARCH; MEDICAL SCHOOL; PATENT; PRIORITY JOURNAL; PROFESSIONALISM; RESIDENCY EDUCATION; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; UNITED STATES;

EID: 35348981185     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.15.1779     Document Type: Article

References (19)

1. Report on Individual and Institutional Conflicts of Interest. Washington, DC: Association of American Universities; October 2001.
2. Association of American Medical Colleges. Protecting Subjects, Preserving Trust, Promoting Progress II: Principles and Recommendations for Oversight of an Institution's Financial Interests in Human Subjects Research. Washington, DC: Task Force on Financial Conflicts of Interest in Clinical Research; 2002.
3. Bok D. Universities in the Marketplace: The Commercialization of Higher Education. Princeton, NJ: Princeton University Press; 2003.
4. Krinsky S. Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? Oxford, England: Rowan & Littlefield; 2004.
5. Campbell EG, Weissman JS, Feibelmann S, Moy B, Blumenthal D. Institutional academic industry relationships: results of case studies. Account Res. 2004;11(2):103-118.
6. Rothman DJ. Medical professionalism - focusing on real issues. N Engl J Med. 2000;342(17):1284-1286.
7. Studdert DM, Mello MM, Brennan TA. Financial conflict of interest in physician relationships with the pharmaceutical industry: self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351(18):1891-1900.
8. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351(18):1885-1890.
9. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med. 2000;342(20):1539-1544.
10. Kassirer JP. On the Take: How Medicine's Complicity With Big Business Can Endanger Your Health. New York, NY: Oxford Press; 2005.
11. Avorn J. Powerful Medicines: The Benefits, Risks and Costs of Prescription Drugs. New York, NY: Random House; 2004.
12. Halperin EC, Hutchison P, Barrier RC. A population based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiat Oncol Biol Phys. 2004;59(5):1477-1483.
13. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454-465.
14. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295(4):429-433.
15. Fowler FJ. Improving Survey Questions: Design and Evaluation. London, England: Sage Publications; 1995. Applied Social Research Methods Series, Vol 38.
16. American Association for Public Opinion Research. Standard definitions: final disposition of case codes and outcome rates for surveys. http://www.aapor.org. Accessed March 30, 2007.
17. Williamson E, Lee C. Conflict alleged in drug firms' education role. Washington Post. June 27, 2007:A3.
18. Carlat D. Diagnosis: conflict of interest. The New York Times. June 13, 2004:A1, A21.
19. Dana J, Lowenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290(2):252-255.